ScholarIQanswers from OpenAlex

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

PaperCitations, authors & open-access status

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours have?

ScholarIQcitation count

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours has 519 citations in the OpenAlex counts ScholarIQ stores.

When was Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours published?

ScholarIQyear

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours has 2022 year in the ScholarIQ index.

What is the open-access status of Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours?

ScholarIQoa status

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours has green oa status in the ScholarIQ index.

What is the DOI of Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours?

ScholarIQdoi

The DOI for Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours is on the source record.

What is the PMID of Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours?

ScholarIQpmid

The PMID for Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours is on the source record.

What is the OpenAlex record for Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours?

ScholarIQopenalex

The OpenAlex for Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial